Ayurvedic food, however, should be understood as part of diabetes management rather than as a replacement for prescribed medicines, insulin, glucose monitoring or medical care. Individual requirements also differ depending on medication, kidney health, weight, age and the severity of diabetes.
The order has emerged alongside a broader expansion of Sanlayan’s activities across radar systems, electronic warfare, counter-drone technology, avionics, RF and microwave electronics, embedded systems and high-power electronics. Recent company-linked disclosures also indicate that Sanlayan has received development work associated with a next-generation DRDO drone-detection radar and electronic-warfare payloads intended for unmanned platforms.
The three-year agreement can also be extended for a further two years by mutual consent, potentially creating a longer relationship extending beyond 2029. The identity of the hyperscaler has not been disclosed publicly, and STL has not identified the precise data-centre locations at which the cables will eventually be deployed.
The overall project is planned with 232.4 MWp of renewable generation capacity and approximately 201 MWh of battery energy storage, meaning a substantial majority of the planned generation capacity has now entered operation. The latest addition leaves approximately 54.8 MWp of planned generation capacity yet to be commissioned if the project is completed according to its currently disclosed configuration.
UltraTech disclosed to the stock exchanges that the newly commissioned facility has an installed capacity of 1,098,000 kilometres of house wires and light-duty cables. The plant forms part of the company’s approximately ₹1,800-crore investment programme announced in February 2025 to establish a significant presence in the wires and cables industry.
HFCL disclosed the agreement on September 1, 2026, saying the contract had been awarded by a global multinational corporation whose identity has not been publicly disclosed. The optical fibre cables will be supplied through HFCL’s overseas wholly owned subsidiary, with deliveries beginning in calendar year 2027 and continuing until December 2029.
The solar facility will have an installed capacity of 110 MW AC and will be developed in Uttar Pradesh specifically under the captive-power model. Instead of selling its electricity into the general market, the project will primarily supply power required for operation of the Namo Bharat system.
The agreement, announced on August 31, 2026, has been signed with Chia Tai Tianqing Pharmaceutical Group Co. Ltd., a subsidiary of Sino Biopharmaceutical Limited. Under the exclusive licence and supply arrangement, Cipla will take responsibility for local clinical development, regulatory submissions and eventual commercialisation of TQB2102 in the licensed territories, while Chia Tai Tianqing will continue to manufacture and supply the investigational medicine.
The Army has identified applications for the system across both conventional warfare and sub-conventional operations, including situations in which combat engineers or assault teams must destroy fortified positions, breach obstacles, neutralise hazardous explosive threats or conduct controlled demolition while reducing the exposure of soldiers.
The research was led by Dr Kozhinjampara R. Mahendran of the BRIC-Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB) in Thiruvananthapuram, with major contributions from researchers at RGCB, the CSIR-Indian Institute of Chemical Biology in Kolkata and Constructor University in Bremen, Germany. The peer-reviewed study was published in Nature Nanotechnology on August 28, 2026 under the title A self-assembled peptide forms α-helical nanopores for ultrasensitive biomarker profiling.
